DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 59 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,217,314 | +23.9% | 425,209 | +20.5% | 0.00% | +100.0% |
| Q2 2023 | $4,212,026 | +63058.3% | 352,766 | -29.3% | 0.00% | -50.0% |
| Q1 2023 | $6,669 | +139.2% | 498,791 | +18.4% | 0.00% | +100.0% |
| Q4 2022 | $2,788 | -99.9% | 421,127 | -6.2% | 0.00% | 0.0% |
| Q3 2022 | $2,970,000 | +517.5% | 448,770 | +518.5% | 0.00% | – |
| Q2 2022 | $481,000 | +23.0% | 72,552 | +82.4% | 0.00% | – |
| Q1 2022 | $391,000 | +50.4% | 39,774 | +165.9% | 0.00% | – |
| Q4 2021 | $260,000 | -26.8% | 14,961 | 0.0% | 0.00% | – |
| Q3 2021 | $355,000 | – | 14,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |